1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Daxor Corporation Announces Signed Trial Agreement From Schnitzler … – MarketWatch (press release)

October 13, 2011Organ Failureadmin

Daxor Corporation Announces Signed Trial Agreement From Schnitzler ...
MarketWatch (press release)
This provides another tool for complex management of heart failure, renal failure and other complex problems associated with volume status questions. SCC will be participating in a multi-center clinical trial (TEAM-HF) which will test whether ...
Daxor Corporation Announces Signed Trial Agreement From Schnitzler ...Benzinga

all 7 news articles »

Post navigation

← 20-Year-old Back Up Squad Bowler Dies Of Heart Failure – Bernama Use of Asthma Controller Meds on the Rise Among U.S. Kids – U.S. News & World Report →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos